ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ADVM Adverum Biotechnologies Inc

10.43
0.43 (4.30%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Adverum Biotechnologies Inc ADVM 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.43 4.30% 10.43 13:00:01
개장가 저가 고가 종가 전일 종가
10.10 10.00 10.69 10.43 10.00
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202421:00GLOBEAdverum Biotechnologies to Participate in Upcoming May..
26/04/202405:05GLOBEAdverum Biotechnologies to Present LUNA 26-week Phase 2..
19/03/202405:05GLOBEAdverum Biotechnologies Reports Fourth Quarter and Full Year..
05/03/202406:40EDGAR2Form S-3 - Registration statement under Securities Act of..
29/02/202406:05GLOBEAdverum Biotechnologies to Participate in the TD Cowen 44th..
23/02/202405:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/02/202405:39EDGAR2Form D - Notice of Exempt Offering of Securities
16/02/202406:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202410:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/02/202422:00GLOBEAdverum Biotechnologies to Participate in the Oppenheimer..
10/02/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202401:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/02/202422:45EDGAR2Form 8-K - Current report
08/02/202421:00GLOBEAdverum Biotechnologies Announces Positive Preliminary..
07/02/202406:47EDGAR2Form 8-K - Current report
06/02/202407:03EDGAR2Form 8-K - Current report
05/02/202421:45GLOBEAdverum Biotechnologies Announces $127.5 Million Private..
02/02/202407:30GLOBEAdverum Biotechnologies will Host Webcast to Review LUNA..
29/01/202422:00GLOBEAdverum Biotechnologies Appoints Romuald Corbau, Ph.D. as..
09/12/202306:11EDGAR2Form 8-K - Current report
08/12/202306:05GLOBEAdverum Biotechnologies to Present LUNA Preliminary Efficacy..
05/12/202306:09EDGAR2Form 8-K/A - Current report: [Amend]
29/11/202306:05GLOBEAdverum Biotechnologies to Participate in the Evercore ISI..
10/11/202306:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:07EDGAR2Form 8-K - Current report
10/11/202306:05GLOBEAdverum Biotechnologies Reports Third Quarter 2023 Financial..
07/11/202309:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202309:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/11/202306:10EDGAR2Form 8-K - Current report
06/11/202322:00GLOBEAdverum Biotechnologies Appoints C. David Nicholson, Ph.D...
05/11/202306:54GLOBEAdverum Biotechnologies Announces 3-Year Efficacy and Safety..
27/09/202305:05GLOBEAdverum Biotechnologies Announces Positive Aflibercept..
22/09/202305:05GLOBEAdverum Biotechnologies to Participate in Upcoming Investor..
19/09/202307:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202305:05GLOBEAdverum Biotechnologies to Participate in the H.C...
22/08/202305:05GLOBEAdverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as..
14/08/202321:00GLOBEAdverum Biotechnologies to Participate in the H.C...
11/08/202305:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:09EDGAR2Form 8-K - Current report
11/08/202305:05GLOBEAdverum Biotechnologies Completes Enrollment of Phase 2 LUNA..
05/08/202305:18EDGAR2Form 8-K - Current report
25/07/202305:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/06/202321:00GLOBEAdverum Biotechnologies Grants License to Ray Therapeutics..
02/06/202321:00GLOBEAdverum Biotechnologies to Participate in the Jefferies..
25/05/202319:30GLOBEAdverum Biotechnologies Announces New Executive Leadership..
18/05/202322:00GLOBEAdverum Biotechnologies Introduces an Intravitreal Gene..

최근 히스토리

Delayed Upgrade Clock